In pancreatic cancer specifically, we observed broader upregulation of numerous immune cell types, but notably no upregulation of the activated CD8+ T cell signature, and greater upregulation of immature vs. activated B-cell signatures. The gene discussed is CD8A; the disease is familial pancreatic carcinoma.